Harbor

Harbor is basically what happens when you stop treating clinical trial software like it's 1995 and actually let AI do the heavy lifting — they've cut EDC build time from 8+ weeks down to 10 minutes by reading your protocol PDF and auto-generating those eCRFs for you, which is honestly kind of insane when you think about how legacy systems still make you build everything manually and then wait days to see your own data. They're also claiming 90% reduction in manual data entry through their human-in-the-loop setup, which hits on the real pain point here: clinical trials are bleeding $25K per delayed day and $15B annually on source data verification because existing EDC systems are basically fancy digital file cabinets that don't actually help you catch errors until weeks later. The flat monthly pricing model is the right move no matter how you slice it — nobody doing clinical trials wants to get hit with per-subject or per-CRF overage invoices on top of everything else that's already stressing them out. They've got BioDynamik and NOVA Genomics signed on as customers, which is decent early traction for a San Diego team, and given that 40,000 new trials start every year with roughly half of them hitting delays, there's definitely a market here if they can actually deliver on that 10-minute claim at scale.